ARE Earnings

ARE reported its earnings on 2026-01-26, showcasing a revenue of 754.41M against an estimate of 738.28M, resulting in a 2.19% surprise. The EPS was 2.16, surpassing the expected 2.15 by 0.47%. The stock experienced a 1.71% price change on the earnings day and a -4.41% change over the next five days, reflecting market reactions to the results.

Following ARE's earnings announcement on 2026-01-26, the stock price moved by 1.71% on the day of the release. Over the subsequent five days, it saw a -4.41% change. Historically, ARE's stock price tends to shift by an average of -2.1% in the 10 days leading up to earnings and -5.82% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate ARE's annual revenue to reach 693.70M, while the EPS is projected at 0.21. These estimates reflect recent revisions, with revenue estimates revised downward by -0.01% and EPS estimates revised downward by -0.22% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ARE's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised downward by -0.01%, while EPS estimates moved revised downward by -0.22%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ARE's stock price typically moves by -2.1% in the 10 days before its earnings and -5.82% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.21 and revenue of 693.70M.

The earnings call reveals several concerns: declining occupancy, reduced FFO guidance, and challenges in leasing due to oversupply. The Q&A highlights uncertainties in the biotech sector and cautious funding, which could affect future leasing. Additionally, the company plans significant asset dispositions, indicating potential financial strain. Despite some positive leasing activity, the overall sentiment is negative, reflecting a challenging environment. The lack of guidance for 2027 and increased free rent further contribute to the negative outlook. Given these factors, the stock price is likely to experience a negative movement in the short term.